Prior to these developments, the market had mired in sluggish activity, most notably with the Dow finishing unchanged on Tuesday for just the third time in two decades. Once re-energized, the major indexes soared into record territory. The Dow set a new 1,000 point milestone, reaching above 28,000 points for the first name, ending the week with it's 11th record close of the year, and fourth straight weeks of gains. Meanwhile, the S&P 500 set new highs and registered its six consecutive week of gains and the Nasdaq also hit a new high. At week's end, the DJIA, S&P 500, and Nasdaq were up 1.2%, 0.9%, and 0.8% respectively.
ETFG Quant Movers – Those ETFs who have had the largest weekly change in their respective, overall ETFG Quant ratings.
ETFG Quant Winners: The top five gainers in ETFG Quant Total Score were Franklin Liberty U.S. Low Volatility ETF (FLLV), Fidelity MSCI Health Care Index ETF (FHLC), JPMorgan Diversified Return International Equity ETF (JPIN), JPMorgan US Minimum Volatility ETF (JMIN) and Vanguard S&P 500 Growth ETF (VOOG).
ETFG Quant Losers: The ETFs recording the biggest declines in their Quant scores this week were Vident International Equity Fund (VIDI), SPDR MSCI Emerging Markets StrategicFactors ETF (QEMM), USCF SummerHaven SHPEI Index Fund (BUY), Invesco Dynamic Leisure and Entertainment ETF (PEJ), and SPDR S&P Telecom ETF (XTL).
ETFG Weekly Select List - The five most highly rated ETFs per Sector, Geographic Region and Strategy as ranked by the ETFG Quant model.
Following the Trump administration's unveiling of its hospital pricing transparency rule, we’d like to highlight the top ETFs within the health care sector in this week’s Select List. Currently, iShares Global Healthcare ETF (IXJ is our top rated health care ETF, followed by iShares Nasdaq Biotechnology ETF (IBB), VanEck Vectors Biotech ETF (BBH), SPDR S&P Pharmaceuticals ETF (XPH), and Invesco Dynamic Pharmaceuticals ETF (PJP).
Thanks for reading ETF Global Perspectives!
ETFG 21 Day Free Trial: https://www.etfg.com/signup/quick
Assumptions, opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice. ETF Global LLC (“ETFG”) and its affiliates and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively ETFG Parties) do not guarantee the accuracy, completeness, adequacy or timeliness of any information, including ratings and rankings and are not responsible for errors and omissions or for the results obtained from the use of such information and ETFG Parties shall have no liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of such information. ETFG PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall ETFG Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of the information contained in this document even if advised of the possibility of such damages.
ETFG ratings and rankings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities or to make any investment decisions. ETFG ratings and rankings should not be relied on when making any investment or other business decision. ETFG’s opinions and analyses do not address the suitability of any security. ETFG does not act as a fiduciary or an investment advisor. While ETFG has obtained information from sources they believe to be reliable, ETFG does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities, financial instruments or strategies mentioned herein may not be suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only correct as of the stated date of their issue. Prices, values, or income from any securities or investments mentioned in this report may fall against the interests of the investor and the investor may get back less than the amount invested. Where an investment is described as being likely to yield income, please note that the amount of income that the investor will receive from such an investment may fluctuate. Where an investment or security is denominated in a different currency to the investor's currency of reference, changes in rates of exchange may have an adverse effect on the value, price or income.
Post a Comment
Note: Only a member of this blog may post a comment.